HopeStage
Back to overview

ADHD studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 121-132 of 1,811
Device study icon
Enrolling By InvitationNCT07145593

Gamma tACS in Attention-Deficit/Hyperactivity Disorder

Official study title

Gamma Transcranial Alternating Current Stimulation in Attention Deficit Hyperactivity Disorder

This study is by invitation only.

In Istanbul
ADHDDevice studyAges 18–40
Countries
Türkiye
Sponsor
Medipol University
Drug study icon
SuspendedNCT05924594

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

Official study title

A Phase 3, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy and Safety Laboratory Classroom Study in Children (6-12) With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)

Recruitment is currently suspended.

Multiple locations, including Maitland
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Cingulate Therapeutics
Drug study icon
CompletedNCT02635035

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

What is this study about?

This study evaluated the effectiveness of Lisdexamfetamine for people with ADHD.

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 18–60
Countries
United States
Sponsor
NYU Langone Health
Other study type icon
CompletedACTRN12609000202268

Effect of a nutritional supplement on attention and mood in adults with Attention-Deficit/Hyperactivity Disorder

Official study title

Investigation into the effect of a nutritional supplement on attention and mood in a clinical sample of adults with Attention-Deficit/Hyperactivity Disorder (ADHD) and mood instability: open label pilot study.

This study has finished and is no longer accepting participants.

In New Zealand
ADHDInterventional studyAges 18+
Countries
New Zealand
Sponsor
Julia Rucklidge
Other study type icon
CompletedACTRN12609000308291

Effect of a nutritional supplement on attention and mood in adults with Attention-Deficit/Hyperactivity Disorder (ADHD)

Official study title

Investigation into the effect of a nutritional supplement on attention and mood in a clinical sample of adults with Attention-Deficit/Hyperactivity Disorder (ADHD): a double blind randomized placebo controlled trial with open label extension.

This study has finished and is no longer accepting participants.

In New Zealand
ADHDInterventional studyAges 16–75
Countries
New Zealand
Sponsor
Julia Rucklidge

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.